Peter Downie
-
- Childhood Cancer Survivors' Quality of Life 16
- Neurology top 10%
- Neuroblastoma Research and Treatments 6
- Genetics top 10%
- Glioma Diagnosis and Treatment 5
- Oncology top 10%
-
- Immunotherapy and Immune Responses 3
-
- Acute Lymphoblastic Leukemia research 10
- Palliative Care and End-of-Life Issues 3
-
- Family Support in Illness 8
-
- Chromatin Remodeling and Cancer 4
- Co-authors
- David M. AshleyLisa OrmeMaria McCarthyFiona J. RadcliffMimi L.K. TangDenise CarusoAlana M. NealeVicki Anderson
- Partner nations
- AustraliaUnited StatesNew Zealand
In The Last Decade
Peter Downie
39 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 91
- Pediatrics, Perinatology and Child Health 421
- Neurology 193
- Genetics 124
- Oncology 274
- Immunology 197
Countries citing papers authored by Peter Downie
This map shows the geographic impact of Peter Downie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Downie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Downie more than expected).
Fields of papers citing papers by Peter Downie
This network shows the impact of papers produced by Peter Downie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Downie. The network helps show where Peter Downie may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter Downie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 9 | |
| 3 | 2023 | 2 | |
| 4 | 2022 | 2 | |
| 5 | 2022 | 2 | |
| 6 | 2021 | 5 | |
| 7 | 2019 | 25 | |
| 8 | 2019 | 9 | |
| 9 | 2015 | 76 | |
| 10 | 2014 | 11 | |
| 11 | 2011 | 14 | |
| 12 | 2011 | 2 | |
| 13 | 2009 | 36 | |
| 14 | 2007 | 39 | |
| 15 | 2007 | 21 | |
| 16 | 2005 | 19 | |
| 17 | 2004 | 128 | |
| 18 | 2003 | 26 | |
| 19 | 2002 | 11 | |
| 20 | 1997 | 2 |
About Peter Downie
Peter Downie is a scholar working on Pediatrics, Perinatology and Child Health, Genetics, Public Health, Environmental and Occupational Health, Neurology and Hematology, having authored 41 papers that have together received 1.1k indexed citations. Recurring topics across this work include Childhood Cancer Survivors' Quality of Life (16 papers), Acute Lymphoblastic Leukemia research (10 papers), Family Support in Illness (8 papers), Neuroblastoma Research and Treatments (6 papers), Glioma Diagnosis and Treatment (5 papers), Chromatin Remodeling and Cancer (4 papers), Immunotherapy and Immune Responses (3 papers) and Palliative Care and End-of-Life Issues (3 papers). The work is most often cited by research in Pediatrics, Perinatology and Child Health (421 citations), Neurology (193 citations), Genetics (124 citations), Oncology (274 citations) and Immunology (197 citations). Peter Downie has collaborated with scholars based in Australia, United States and New Zealand. Frequent co-authors include David M. Ashley, Lisa Orme, Maria McCarthy, Fiona J. Radcliff, Mimi L.K. Tang, Denise Caruso, Alana M. Neale, Vicki Anderson, Kathy Pritchard‐Jones and Marianne Naafs-Wilstra. Their work appears in journals such as Pediatric Blood & Cancer, Cancer, Cancers, Journal of Cancer Survivorship and BMJ Supportive & Palliative Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.